Schedule 13D ownership disclosure

Innate Pharma SA

Ordinary Shares, EUR0.05 nominal value per share · CUSIP: 45781K105

Event date: 2025-12-22

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • AstraZeneca PLCReported CIK 0000901832

    Shares: 7,825,501.00 · Class: 8.3%

  • MedImmune LimitedReported CIK 0001790714

    Shares: 7,825,501.00 · Class: 8.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-26-011298
Form type
SCHEDULE 13D/A
Filer
ASTRAZENECA PLC
CIK
CIK 901832
Filed
Feb 06, 2026
Reporting period
Dec 22, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub